Overall survival analysis adjusting for treatment effect after crossover in a phase 3 study evaluating idelalisib in combination with rituximab in relapsed CLL
BRITISH JOURNAL OF HAEMATOLOGY（2016）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined